These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 22578375

  • 1. Plasma components: properties, differences, and uses.
    Benjamin RJ, McLaughlin LS.
    Transfusion; 2012 May; 52 Suppl 1():9S-19S. PubMed ID: 22578375
    [Abstract] [Full Text] [Related]

  • 2. Update on pathogen reduction technology for therapeutic plasma: an overview.
    Solheim BG, Seghatchian J.
    Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
    [Abstract] [Full Text] [Related]

  • 3. Pathogen reduction of blood components.
    Solheim BG.
    Transfus Apher Sci; 2008 Aug; 39(1):75-82. PubMed ID: 18602343
    [Abstract] [Full Text] [Related]

  • 4. Clinical use of fresh-frozen plasma and cryoprecipitate in neonatal intensive care unit.
    Motta M, Del Vecchio A, Radicioni M.
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 1():129-31. PubMed ID: 21942611
    [Abstract] [Full Text] [Related]

  • 5. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma.
    Smith J, Rock G.
    Transfusion; 2010 Apr; 50(4):926-31. PubMed ID: 20051060
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
    Mintz PD, Neff A, MacKenzie M, Goodnough LT, Hillyer C, Kessler C, McCrae K, Menitove JE, Skikne BS, Damon L, Lopez-Plaza I, Rouault C, Crookston KP, Benjamin RJ, George J, Lin JS, Corash L, Conlan MG.
    Transfusion; 2006 Oct; 46(10):1693-704. PubMed ID: 17002625
    [Abstract] [Full Text] [Related]

  • 8. [Therapeutic plasma exchange in the treatment of the hereditary thrombotic thrombocytopenic purpura].
    Cermáková Z, Korístka M, Korístková B, Hrdlicková R, Suláková T, Furková J, Kovárová P.
    Cas Lek Cesk; 2009 Oct; 148(10):493-6. PubMed ID: 20662412
    [Abstract] [Full Text] [Related]

  • 9. [Indications for fresh frozen plasma: evaluation of virus inactivating preparations].
    Pindur G, Kiesewetter H, Seyfert UT, Wenzel E.
    Beitr Infusionsther; 1993 Oct; 31():74-80. PubMed ID: 7693268
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
    Osselaer JC, Debry C, Goffaux M, Pineau J, Calomme G, Dubuc E, Chatelain B, Vandendaele MC, Hsu J, Rheinschmidt M, Lin L.
    Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
    [Abstract] [Full Text] [Related]

  • 12. Plasma and plasma derivatives in therapeutic plasmapheresis.
    McLeod BC.
    Transfusion; 2012 May; 52 Suppl 1():38S-44S. PubMed ID: 22578370
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Guideline for the use of fresh-frozen plasma. Medical Directors Advisory Committee, National Blood Transfusion Council.
    S Afr Med J; 1998 Oct; 88(10):1344-7. PubMed ID: 9807194
    [Abstract] [Full Text] [Related]

  • 15. [Reasons for fresh frozen plasma transfusion in a general hospital].
    Pita-Ramírez L, Cabrera Carbajal BE, Ortega Zavala C.
    Rev Invest Clin; 1999 Oct; 51(2):89-92. PubMed ID: 10410587
    [Abstract] [Full Text] [Related]

  • 16. Algorithmic and consultative integration of transfusion medicine and coagulation: a personalized medicine approach with reduced blood component utilization.
    Brown RE, Dorion RP, Trowbridge C, Stammers AH, Fitt W, Davis J.
    Ann Clin Lab Sci; 2011 Oct; 41(3):211-6. PubMed ID: 22075502
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light.
    Yarranton H, Lawrie AS, Mackie IJ, Pinkoski L, Corash L, Machin SJ.
    Transfusion; 2005 Sep; 45(9):1453-8. PubMed ID: 16131377
    [Abstract] [Full Text] [Related]

  • 19. Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura.
    Scully M, Longair I, Flynn M, Berryman J, Machin SJ.
    Vox Sang; 2007 Aug; 93(2):154-8. PubMed ID: 17683359
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.